ArticleEClinicalMedicine2026

Intraperitoneal and intravenous paclitaxel plus S-1 and sintilimab as first-line treatment for gastric cancer with peritoneal metastasis: a single-arm phase 2 trial (DRAGON-09).

Hong Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.